NEW YORK (GenomeWeb News) – Poland's University of Lodz will use Cellectricon's cell-based screening system in its genomic research programs, the company said today.

Under the agreement, the university will use the Cellaxess HT system for high-throughput transfection, which the company said enables the delivery of any genetic material to cells without the use of reagents.

The university bought the Cellaxess system with funding from Poland's Innovative Economy Operational Program, which is supported in part by the EU's European Regional Development Fund.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.